Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Opioid Litigation Pushes American Pain Society Into Bankruptcy

Executive Summary

Labeled by plaintiffs as a 'front group' for opioid makers, the organization was pulled into the multidistrict litigation in Ohio and filed for Chapter 7 bankruptcy in June. It ceased operations in July.

You may also be interested in...



Behind-The-Scenes Battles As Opioid MDL Jury Trial Nears

Expert witness "battle plan," requests for summary judgment, and squabble over DEA drug distribution data offer preview of the first US bellwether trial against opioid manufacturers, distributors and pharmacies.

Endo And Allergan Could Edge Out Of Opioid Bellwether Trial Spotlight With Proposed Settlements

Companies reach agreements in principal with plaintiffs in bellwether trial in the US multidistrict litigation as court date nears; plaintiffs narrow their claims from 11 to seven.

Opioid Exposure Risk Intensifying For Generic Drug Makers

Business fundamentals took a back seat to opioid litigation in the second quarter for generic drug makers, including Teva, Mallinckrodt and Endo Pharmaceuticals.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS140722

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel